First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
LDE225 and Paclitaxel in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.
- Status
- UNKNOWN
- Phase
- PHASE1
A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-012/KEYNOTE-012)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011)
- Status
- COMPLETED
- Phase
- PHASE1
A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics
- Status
- UNKNOWN
- Phase
- PHASE1
Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
EUS-FNA for Patients With Antithrombotic Agents
- Status
- COMPLETED
- Phase
- N/A
A Phase 1 Study of MORAb-004 in Patients With Solid Tumor (Study: MORAb-004-J081-103)
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread
- Status
- COMPLETED
- Phase
- PHASE1
A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin
- Status
- TERMINATED
- Phase
- PHASE1